Ohtsu A - Search Results

1

Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer.

Takahashi S, Kinoshita T, Konishi M, Nakagouri T, Inoue K, Ono M, Sugitou M, Ohtsu A, Boku N, Yoshida S. Takahashi S, et al. Among authors: ohtsu a. Gastric Cancer. 2001;4(4):192-7. doi: 10.1007/s10120-001-8009-5. Gastric Cancer. 2001. PMID: 11846062 Clinical Trial.

2

Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.

Boku N, Chin K, Hosokawa K, Ohtsu A, Tajiri H, Yoshida S, Yamao T, Kondo H, Shirao K, Shimada Y, Saito D, Hasebe T, Mukai K, Seki S, Saito H, Johnston PG. Boku N, et al. Among authors: ohtsu a. Clin Cancer Res. 1998 Jun;4(6):1469-74. Clin Cancer Res. 1998. PMID: 9626464 Clinical Trial.

3

Chemotherapy and chemoradiotherapy for esophageal cancer.

Ohtsu A, Yoshida S. Ohtsu A, et al. Crit Rev Oncol Hematol. 1998 Sep;28(3):173-80. doi: 10.1016/s1040-8428(98)00020-1. Crit Rev Oncol Hematol. 1998. PMID: 9793745 Review. No abstract available.

4

Retrospective study of hyponatremia in gastric cancer patients treated with a combination chemotherapy of 5-fluorouracil and cisplatin: a possible warning sign of severe hematological toxicities?

Boku N, Ohtsu A, Nagashima F, Muto M, Shinkai T, Yoshida S. Boku N, et al. Among authors: ohtsu a. Jpn J Clin Oncol. 2001 Aug;31(8):382-7. doi: 10.1093/jjco/hye085. Jpn J Clin Oncol. 2001. PMID: 11574631

5

Combination chemotherapy of irinotecan plus cisplatin for advanced gastric cancer: efficacy and feasibility in clinical practice.

Yoshida M, Boku N, Ohtsu A, Muto M, Nagashima F, Yoshida S. Yoshida M, et al. Among authors: ohtsu a. Gastric Cancer. 2001;4(3):144-9. doi: 10.1007/pl00011737. Gastric Cancer. 2001. PMID: 11760080

6

Sequential methotrexate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: a retrospective study.

Tahara M, Ohtsu A, Boku N, Nagashima F, Muto M, Sano Y, Yoshida M, Mera K, Hironaka S, Tajiri H, Yoshida S. Tahara M, et al. Among authors: ohtsu a. Gastric Cancer. 2001;4(4):212-8. doi: 10.1007/s10120-001-8012-x. Gastric Cancer. 2001. PMID: 11846065

7

An early phase II study of 5-fluorouracil combined with cisplatinum as a second line chemotherapy against metastatic gastric cancer.

Ohtsu A, Yoshida S, Saito D, Shimada Y, Miyamoto K, Fujii T, Yoshino M, Yoshimori M. Ohtsu A, et al. Jpn J Clin Oncol. 1991 Apr;21(2):120-4. doi: 10.1093/oxfordjournals.jjco.a039440. Jpn J Clin Oncol. 1991. PMID: 2067126 Clinical Trial.

8

Expression of integrin alpha 3 in gastric and colorectal cancers: its relation to wall contraction and mode of invasion.

Boku N, Yoshida S, Ohtsu A, Fujii T, Koba I, Oda Y, Ryu M, Matsumoto T, Hasebe T, Hosokawa K, et al. Boku N, et al. Among authors: ohtsu a. Jpn J Cancer Res. 1995 Oct;86(10):934-40. doi: 10.1111/j.1349-7006.1995.tb03004.x. Jpn J Cancer Res. 1995. PMID: 7493912 Free PMC article.

9

Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG).

Ohtsu A, Shimada Y, Yoshida S, Saito H, Seki S, Morise K, Kurihara M. Ohtsu A, et al. Eur J Cancer. 1994;30A(14):2091-3. doi: 10.1016/0959-8049(94)00350-e. Eur J Cancer. 1994. PMID: 7857709 Clinical Trial.

10

[Recent advances in chemotherapy for advanced gastric cancer: from the standpoint of survival advantages].

Ohtsu A, Yoshida S, Miyata Y, Shimada Y. Ohtsu A, et al. Gan To Kagaku Ryoho. 1995 Mar;22(4):444-50. Gan To Kagaku Ryoho. 1995. PMID: 7887636 Review. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

458 results

Search Page

Filters